Login / Signup

Intracranial hemorrhage in large vessel occlusion patients receiving endovascular thrombectomy with or without intravenous alteplase: a secondary analysis of the DIRECT-MT trial.

Xiaowei HuYu ZhouJohanna OspelFeirong YaoYizhi LiuHui WangBo LiPinjing HuiPengfei YangYongwei ZhangLei ZhangZifu LiPengfei XingHuaizhang ShiHongxing HanShouchun WangQi FangJianmin Liunull null
Published in: Journal of neurointerventional surgery (2022)
Our data showed that in the DIRECT-MT trial, alteplase did not increase overall ICH for large vessel occlusion patients treated with thrombectomy, but it increased the parenchymal hematoma rate.
Keyphrases
  • acute ischemic stroke
  • phase iii
  • study protocol
  • phase ii
  • clinical trial
  • high dose
  • open label
  • low dose
  • machine learning
  • artificial intelligence
  • placebo controlled